Equity
Unrealized Gains on Investments
Medtronic Unrealized Gains on Investments decreased by 25.0% to $54M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 260.0%, from $15M to $54M. Over 4 years (FY 2021 to FY 2025), Unrealized Gains on Investments shows a downward trend with a -36.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2018
Last reportedQ3 2026Feb 24, 2026
Metric ID:
unrealized_gains_on_investmentsHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $155M | $162M | $111M | $59M | $5M | $5M | $1M | $7M | $6M | $5M | $4M | $14M | $7M | $18M | $22M | $15M | $26M | $33M | $72M | $54M |
| QoQ Change | — | +4.5% | -31.5% | -46.8% | -91.5% | +0.0% | -80.0% | +600.0% | -14.3% | -16.7% | -20.0% | +250.0% | -50.0% | +157.1% | +22.2% | -31.8% | +73.3% | +26.9% | +118.2% | -25.0% |
| YoY Change | — | — | — | — | -96.8% | -96.9% | -99.1% | -88.1% | +20.0% | +0.0% | +300.0% | +100.0% | +16.7% | +260.0% | +450.0% | +7.1% | +271.4% | +83.3% | +227.3% | +260.0% |
Range$1M – $162M
CAGR-19.9%
Avg YoY Growth+100.9%
Median YoY Growth+51.7%
Unrealized Gains on Investments at Other Companies
Frequently Asked Questions
- What is Medtronic's unrealized gains on investments?
- Medtronic (MDT) reported unrealized gains on investments of $54M in Q4 2025.
- How has Medtronic's unrealized gains on investments changed year-over-year?
- Medtronic's unrealized gains on investments increased by 260.0% year-over-year, from $15M to $54M.
- What is the long-term trend for Medtronic's unrealized gains on investments?
- Over 4 years (2021 to 2025), Medtronic's unrealized gains on investments has grown at a -36.0% compound annual growth rate (CAGR), from $155M to $26M.